14 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
10 Jan 22
Regulation FD Disclosure
8:17am
strain (Kuykendall) Targets ICAM expressing tumors Indications Patient Samples Tested (N) ICAM+ Prevalence NSCLC 97 72% HCC 69 72% RCC 67 79% Note … vRNA encoding for the synthetic Seneca Valley Virus (SVV) Targets SCLC & neuroendocrine prostate Induces tumor regression & improves survival
10-K
qos5m0mjsibyvv11 bv
10 Mar 21
Annual report
4:12pm
424B4
cj60z7zoj1
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
0ok4t3 va75xri0
28 Jan 21
Draft registration statement
12:00am
424B4
s3wuo9u
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
nh2yrjy2hsdm3 44h
11 Sep 20
IPO registration
4:49pm
CORRESP
tlydxg0m8pbvsnot4kx7
11 Sep 20
Correspondence with SEC
12:00am
DRS/A
w4wo7lnw1jjz3sj up
26 Aug 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next